You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 168 No. 1, January 14, 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

COMMENTS AND OPINIONS
Estimating Cardiovascular Risk

Bastian M. Seidel, MD, MRCGP, FRACGP; Nigel Stocks, BSc, MBBS, MD, Dip PH, FRACGP, FAFPHM

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In the May 28th issue of the Archives, Weymiller et al1 highlight the significant benefit of patient-tailored decision aids on adherence to statin therapy in patients with type 2 diabetes mellitus. They also report that patients who used the decision aid were estimating their own cardiovascular risk and potential absolute cardiovascular risk reduction more accurately, indicating the importance of specifically designed decision aids to enhance knowledge and understanding of cardiovascular risk.

However, for estimating cardiovascular risk the authors used a pen-and-paper risk estimator based on data from the United Kingdom Prospective Diabetes Study (UKPDS).2 This risk estimator calculates the coronary heart disease (CHD) risk rather than cardiovascular disease (CVD) risk.3 However, CVD is a combined end point of CHD (fatal and nonfatal myocardial infarction and new angina) plus stroke (fatal and nonfatal stroke and . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Estimating Cardiovascular Risk—Reply
Audrey Weymiller and Victor M. Montori
Arch Intern Med. 2008;168(1):111.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Helping Patients With Type 2 Diabetes Mellitus Make Treatment Decisions: Statin Choice Randomized Trial
Audrey J. Weymiller, Victor M. Montori, Lesley A. Jones, Amiram Gafni, Gordon H. Guyatt, Sandra C. Bryant, Teresa J. H. Christianson, Rebecca J. Mullan, and Steven A. Smith
Arch Intern Med. 2007;167(10):1076-1082.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.